{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:03:22Z","timestamp":1785420202533,"version":"3.56.0"},"reference-count":31,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR075626"],"award-info":[{"award-number":["RS-2022-NR075626"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2022-NR075626"],"award-info":[{"award-number":["RS-2022-NR075626"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Soonchunhyang University Research Fund","award":["2026-0025"],"award-info":[{"award-number":["2026-0025"]}]},{"award":["2026-0025"],"award-info":[{"award-number":["2026-0025"]}],"id":[{"id":"https:\/\/ror.org\/03qjsrb10","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Graves\u2019 orbitopathy (GO) is a representative extrathyroidal manifestation of autoimmune thyroid disease. Despite extensive research, the precise pathogenic mechanisms remain incompletely understood. Moreover, the lack of an ideal animal model has limited in vivo investigation, with most studies relying on in vitro systems using orbital fibroblasts. In this review, we discuss currently available mouse models of GO and recent advances in experimental modeling strategies, aiming to provide an integrated framework for future research.<\/jats:p>","DOI":"10.3390\/medicina62050961","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:05:08Z","timestamp":1779721508000},"page":"961","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mouse Model of Graves\u2019 Orbitopathy in Current Research and Future Perspectives"],"prefix":"10.3390","volume":"62","author":[{"given":"Gyeong Min","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, 1, Singil-ro, Yeongdeungpo-gu, Seoul 07441, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4723-054X","authenticated-orcid":false,"given":"Wook Hyun","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170, Jomaru-ro, Bucheon 14584, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeseul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Yonsei Eagle Eye Center, 39, Daewangpangyo-ro 606beon-gil, Bundang-gu, Seongnam 13524, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung In","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Soonchunhyang University College of Medicine, 22, Soonchunhyang-ro, Sinchang-myeon, Asan 31538, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-3712","authenticated-orcid":false,"given":"Sun Young","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170, Jomaru-ro, Bucheon 14584, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: Review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European thyroid association\/European group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur. Thyroid. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2014-3014","article-title":"Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves\u2019 orbitopathy: A randomized controlled study","volume":"100","author":"Salvi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Fallahi, P., Ferrari, S.M., Elia, G., Ragusa, F., Paparo, S.R., Patrizio, A., Camastra, S., Miccoli, M., Cavallini, G., and Benvenga, S. (2021). Cytokines as targets of novel therapies for Graves\u2019 ophthalmopathy. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.654473"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12016-016-8562-7","article-title":"Review of mouse models of Graves\u2019 disease and orbitopathy-novel treatment by induction of tolerance","volume":"52","author":"Ungerer","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of Graves\u2019 ophthalmopathy","volume":"329","author":"Bahn","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MED.0000000000000186","article-title":"Animal models of Graves\u2019 disease and Graves\u2019 orbitopathy","volume":"22","author":"Nagayama","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0035-1555956","article-title":"Modeling Graves\u2019 orbitopathy in experimental Graves\u2019 disease","volume":"47","author":"Banga","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"109436","DOI":"10.1016\/j.exer.2023.109436","article-title":"Development and application of animal models to study thyroid-associated ophthalmopathy","volume":"230","author":"Shen","year":"2023","journal-title":"Exp. Eye Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.survophthal.2009.06.009","article-title":"Immunopathogenesis of thyroid eye disease: Emerging paradigms","volume":"55","author":"Naik","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xia, N., Ye, X., Hu, X., Song, S., Xu, H., Niu, M., Wang, H., and Wang, J. (2017). Simultaneous induction of Graves\u2019 hyperthyroidism and Graves\u2019 ophthalmopathy by TSHR genetic immunization in BALB\/c mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174260"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","article-title":"A novel murine model of Graves\u2019 hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor","volume":"168","author":"Nagayama","year":"2002","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: Retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kim, C., Park, J.H., Choi, Y.J., Jun, H.O., Chung, J.K., Park, T.K., Yoon, J.S., Yang, J.W., and Jang, S.Y. (2024). Impact of ibrutinib on inflammation in a mouse model of Graves\u2019 orbitopathy. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1420024"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s40618-024-02344-z","article-title":"Mouse model of Graves\u2019 orbitopathy induced by the immunization with TSHR A and IGF-1R \u03b1 subunit gene","volume":"47","author":"Wu","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/a-2161-5417","article-title":"Graves\u2019 orbitopathy models: Valuable tools for exploring pathogenesis and treatment","volume":"55","author":"Wang","year":"2023","journal-title":"Horm. Metab. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2006.02.047","article-title":"Pathogenesis of graves ophthalmopathy: Implications for prediction, prevention, and treatment","volume":"142","author":"Garrity","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"Krieger","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.12.6.12","article-title":"Establishment and Comparison of Two Different Animal Models of Graves\u2019 Orbitopathy","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fang, S., Lu, Y., Huang, Y., Zhou, H., and Fan, X. (2021). Mechanisms that underly T cell immunity in Graves\u2019 orbitopathy. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.648732"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1038\/s41598-020-64402-9","article-title":"Enhanced orbital adipogenesis in a mouse model of T-cell-mediated autoimmunity, zymosan A-treated SKG mice: Implications for Graves\u2019 ophthalmopathy","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1089\/thy.2023.0299","article-title":"Cre-loxP System-Based Mouse Model for Investigating Graves\u2019 Disease and Associated Orbitopathy","volume":"33","author":"Bao","year":"2023","journal-title":"Thyroid"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating gut microbiota in a mouse model of Graves\u2019 orbitopathy and its impact on induced disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/961\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:34:06Z","timestamp":1779723246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050961"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050961","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}